Published in Neurochem Res on June 01, 1977
Colorimetric Estimation of Succinic Dehydrogenase by Triphenyltetrazolium Chloride. Science (1949) 4.77
Properties of an ATP-binding protein isolated from membranes of nerve endings. Biochim Biophys Acta (1968) 1.59
Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol (1978) 1.33
Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. Am J Med Genet (1997) 1.30
Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry (2000) 1.16
Purification of the opiate receptor from rat brain. Proc Natl Acad Sci U S A (1981) 1.04
Electrophysiological, behavioral, and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain. J Neurosci Res (1978) 1.03
Solubilization of the opiate receptor. Life Sci (1980) 1.00
Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplant (2000) 0.98
Cocaine and phencyclidine inhibition of the acetylcholine receptor: analysis of the mechanisms of action based on measurements of ion flux in the millisecond-to-minute time region. Proc Natl Acad Sci U S A (1982) 0.95
Stereoselective muscarinic acetylcholine and opiate receptiors in human phagocytic leukocytes. Biochem Pharmacol (1980) 0.93
Interrelationships between phosphates and calcium in bioelectric phenomena. Int Rev Neurobiol (1966) 0.93
Sites and mechanisms for nicotine's action in the brain. Neurosci Biobehav Rev (1981) 0.93
Biochemical analysis of isolated bullfrog sarcolemma. Biochim Biophys Acta (1966) 0.91
Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol (1977) 0.91
Cocaine: mechanism of inhibition of a muscle acetylcholine receptor studied by a laser-pulse photolysis technique. Proc Natl Acad Sci U S A (1995) 0.90
Stimulation of phospholipase A2 and secretion of catecholamines from brain synaptosomes by potassium and A23187. J Neurochem (1983) 0.89
Relationship of calcium and phosphates to bioelectric phenomena in the excitatory membrane. Perspect Biol Med (1965) 0.87
Immunocytochemistry of receptors using anti-idiotypic antibodies. Methods Enzymol (1989) 0.85
Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res (1979) 0.84
Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. Am J Med Genet (2000) 0.84
Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci (1977) 0.84
Stereospecific 3H-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic nature. Life Sci (1980) 0.83
Preparation and characterization of calcium-binding and other hydrophobic proteins from synaptic membranes. Biochim Biophys Acta (1976) 0.82
Uptake and biliary excretion of Cu64 in rabbits in relation to blood ceruloplasmin. Proc Soc Exp Biol Med (1965) 0.82
Fluidity in hydrophobic protein regions of synaptic membranes. Eur J Biochem (1974) 0.82
Preparation and spectroscopic characterization of molecular species of brain phosphatidylserines. Chem Phys Lipids (1980) 0.81
Early elevations of glycosidase, acid phosphatase, and acid proteolytic enzyme activity in denervated skeletal muscle. Exp Neurol (1974) 0.81
In vivo incorporation of l-[14C]serine into phospholipids and proteins of the subcellular fractions of developing rat brain. J Neurochem (1966) 0.81
[3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors. Biochem Pharmacol (1986) 0.80
Carbamate ester latentiation of physiologically active amines. J Med Chem (1970) 0.79
Separation of brain phosphatidylserines according to degree of unsaturation by thin-layer chromatography. Anal Biochem (1976) 0.79
Stereospecific morphine adsorption to phosphatidyl serine and other membranous components of brain. Eur J Pharmacol (1975) 0.79
Isolation of a nicotine binding site from rat brain by affinity chromatography. Proc Natl Acad Sci U S A (1983) 0.79
[3H]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues. Biochem Pharmacol (1990) 0.78
Biochemical studies on isolated nerve endings and other particulates of bullfrog brain. Biochim Biophys Acta (1967) 0.78
Phospholipid changes in synaptic membranes by lipolytic enzymes and subsequent restoration of opiate binding with phosphatidylserine. Biochim Biophys Acta (1978) 0.78
Enhancement of stereospecific opiate binding to neural membranes by phosphatidyl serine. Eur J Pharmacol (1976) 0.78
Antagonism of nicotine's action by cocaine analogs. Life Sci (1995) 0.78
Expression and characterization of the rat alpha 4 beta 2 neuronal nicotinic cholinergic receptor in baculovirus-infected insect cells. J Neurosci Res (1996) 0.78
Barrel rotation and prostration by vasopressin and nicotine in the vestibular cerebellum. Pharmacol Biochem Behav (1986) 0.78
Two classes of arginine vasopressin binding sites on rat brain membranes. Neurochem Res (1985) 0.77
Differential effect of sodium and potassium on calcium adsorption to stearic acid monolayers. Biochim Biophys Acta (1968) 0.77
Evidence for a noncholinergic site for nicotine's action in brain: psychopharmacological, electrophysiological and receptor binding studies. Arch Int Pharmacodyn Ther (1979) 0.77
Opioid receptor antagonist affinity ligands: 6 beta-bromoacetamido-6-desoxynaltrexone and 6 beta-thioglycolamido-6-desoxynaltrexone. Neurochem Res (1992) 0.77
14 beta-(2-bromoacetamido)morphine and 14 beta-(2-bromoacetamido)morphinone. J Med Chem (1983) 0.77
Behavior and receptor changes after kainate lesioning of nodular cerebellum. Pharmacol Biochem Behav (1986) 0.76
Nicotine antagonists: phosphoinositide turnover and receptor binding to determine muscarinic properties. Biochem Pharmacol (1989) 0.76
Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. II. Biochemistry. Brain Res (1986) 0.76
Chemical requirements of vasopressins for barrel rotation convulsions and reversal by oxytocin. J Neurosci Res (1980) 0.75
Characterization of a purified nicotinic receptor from rat brain by using idiotypic and anti-idiotypic antibodies. Proc Natl Acad Sci U S A (1987) 0.75
Probing ion channels and recognition sites of neuronal nicotinic cholinergic receptors with novel nicotine affinity and other ligands. Ann N Y Acad Sci (1995) 0.75
Calcium-adenosine triphosphate-lipid interactions and their significance in the excitatory membrane. Neurosci Res (N Y) (1969) 0.75
Molecular mechanisms of the brain reward system. NIDA Res Monogr (1996) 0.75
Synthesis of compounds with potential psychotomimetic activity. IV. J Med Chem (1968) 0.75
Community health nursing in Northern Canada. Nurs Mirror Midwives J (1975) 0.75
Differences in ligand binding and phosphoinositide turnover between M1 muscarinic receptor gene transfected cells and mouse and rat brain membranes. Pharmacol Biochem Behav (1994) 0.75
Acute and chronic effects of nicotine in rats and evidence for a noncholinergic site of action. NIDA Res Monogr (1979) 0.75
Synthesis of the first highly potent bridged nicotinoid 9-Azabicyclo[4.2.1]nona[2,3-c]pyridine (pyrido[3,4-b]homotropane). J Am Chem Soc (1986) 0.75
Synthesis and biological characterization of pyridohomotropanes. Structure-activity relationships of conformationally restricted nicotinoids. J Med Chem (1988) 0.75
Use of phospholipase A to compare phospholipid organization in synaptic membranes, myelin, and liposomes. J Membr Biol (1982) 0.75
Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain. Biochem Pharmacol (1986) 0.75
Mechanisms of tolerance and dependence: an overview. NIDA Res Monogr (1984) 0.75
Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy. Biochem Pharmacol (1988) 0.75
Differential desensitization of muscarinic receptor-stimulated phosphoinositide turnover in the rat brain. Neurochem Int (1990) 0.75
The action of some CNS and local anesthetic drugs on the stimulated glycolysis of frog sartorius muscle. Int J Neuropharmacol (1966) 0.75
Membrane mechanisms of drugs of abuse. A review of the conference. Prog Clin Biol Res (1979) 0.75
Investigations on the neural tissue-limb deplant of the salamander. Exp Brain Res (1968) 0.75
Solubilization and characterization of muscarinic receptors from bovine brain. Life Sci (1984) 0.75
Binding of optically pure (--)-[3H]nicotine to rat brain membranes. FEBS Lett (1983) 0.75
Phencyclidine inhibition of the acetylcholine receptor: measurement of cation flux in a sympathetic neuronal cell line using 22Na+ and spectroscopic detection of Cs+. Arch Biochem Biophys (1983) 0.75
Molecular characteristics of brain opiate and nicotine receptors. Biomembranes (1983) 0.75
Studies on the neural tissue-limb deplant of salamander. Exp Neurol (1969) 0.75
Selective calcium-alkali metal exchange in a synaptic membrane protein. Experientia (1974) 0.75
Influence of an anticholinergic psychotomimetic agent on behaviour in cats controlled by an auditory stimulus. Neuropharmacology (1974) 0.75
Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. I. Electrophysiology and morphology. Brain Res (1986) 0.75
Nucleotide content, calcium accumulation, and phosphate metabolism in subcellular fractions of rat brain. Biochim Biophys Acta (1968) 0.75
Ion exchange chromatography of some acidic and aromatic amino acids. J Chromatogr (1966) 0.75
Comparison of the binding of optically pure (-)- and (+)- [3H]nicotine to rat brain membranes. Neurochem Res (1985) 0.75
Behavioral and biochemical studies in rats after chronic exposure to nicotine. NIDA Res Monogr (1984) 0.75
Solubilization and purification of the Ni-stimulated arginine-vasopressin binding site of rat brain membranes. Neurochem Res (1987) 0.75
Arginine vasopressin-anti-idiotypic immunostaining of human brain cells. J Neuroendocrinol (1990) 0.75
Effect of calcium and physical state of neutral membranes on phosphatidylserine requirement for opiate binding. Mol Pharmacol (1980) 0.75
Effect of calcium, sodium, and aluminum ions on electrical and physical properties of bimolecular lipid membranes. Int J Neurosci (1973) 0.75
Covalent interaction of [3H]-dopamine with rat brain proteins in vivo and with the dopamine-reuptake site of nerve endings in vitro. J Neurosci Res (1981) 0.75
Specific binding and metabolism of (-)- and (+)-[3H]-nicotine in isolated rat hepatocytes and hepatocyte membranes. Arch Int Pharmacodyn Ther (1985) 0.75
Inhibition of opiate binding to brain membranes by enzymically inactivated peptidases and tryptic fragments from autolysis. Subst Alcohol Actions Misuse (1980) 0.75
A benzilate ester of pyrrolizidine and its stereochemical relationship to other psychotomimetic glycolates. Life Sci (1974) 0.75
Affinity labeling and purification of the opiate receptor from rat brain. Adv Biochem Psychopharmacol (1982) 0.75
Immobilization of opiates by membrane lipids. Mol Pharmacol (1977) 0.75
Structure-activity relationships for various N-alkylcarbamyl esters of choline with selective nicotinic cholinergic properties. Biochem Pharmacol (1991) 0.75
The biochemical and behavioral effects of phospholipase A2 and morphine microinjections in the periaqueductal gray of the rat. Life Sci (1985) 0.75
Recent developments in the chemistry and biochemistry of narcotics. IMJ Ill Med J (1966) 0.75
5-Isothiocyanonicotine: a high-affinity irreversible ligand for brain nicotinic receptors. Biochem Pharmacol (1994) 0.75
[3H]benzylpempidine, a new radioligand for probing a putative channel site on nicotinic cholinergic receptors. Life Sci (1997) 0.75
Interfacial adsorption of a psychotomimetic drug using liquid scintillation. J Pharm Sci (1973) 0.75
Action of ATP on the neural tissue-limb deplant of the salamander. Int J Neurosci (1973) 0.75
4-Bromoacetamidoprocaine: an affinity ligand for brain muscarinic and nicotinic cholinergic receptors. Neurochem Res (1992) 0.75
Receptor binding characteristics of a 3H-labeled azetidine analogue of nicotine. Biochem Pharmacol (1987) 0.75
A psychosis-producing drug as a tool in studying nerve excitation. Recent Adv Biol Psychiatry (1965) 0.75